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EUROPLAN (http://www.europlanproject.eu) is a three
year EU funded project (2008-2011) coordinated by the
Italian National Centre for Rare Diseases (Istituto Super-
iore di Sanità, Italy), which involves 30 Countries and
EURORDIS. The Council Recommendations on Eur-
opean Action in the field of Rare Diseases (RD) which
was adopted by the EU Council in June 2009 calls upon
Member States to adopt National Plans for RD, before
the end of 2013. In line with this, EUROPLAN is an
operational measure within the European strategy in the
field of RD.
The project aims at a) elaborating recommendations
on the different steps to develop a national plan or
strategy; they will include priority areas and actions of
intervention supporting the harmonisation of public
health strategies on RD throughout Europe; b) select
indicators for monitoring the implementation and evalu-
ating the impact of national plans or strategies.
In order to turn the Council Recommendation into
concrete actions in favour of RD patients at national
level, several rare disease patient alliances, coordinated
by EURORDIS in conjunction with national authorities,
are organising National Conferences to be held in 16
Countries in 2010. During the National Conferences
local stakeholders will discuss the EUROPLAN recom-
mendations and the main elements of the European
strategy on RD, with the aim to assess their transferabil-
ity in their own Country.
In conclusion, EUROPLAN is collecting information
on EU Member States initiatives contributing to share
experiences, data and effective strategies to address RD;
is promoting the development of RD plan or strategy
trough recommendations and indicators; is increasing
awareness on RD and the recommendations will also
serve as an important advocacy instrument at policy
level. The EUROPLAN outcomes will support and
encourage EU MS in developing national health policies
to ensure equal access and availability of prevention,
diagnosis and treatment for citizens with RD.
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